Opportunity ID: 312648

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-19-183
Funding Opportunity Title: Biology of Bladder Cancer (R01 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.393 — Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 05, 2019
Last Updated Date: Feb 05, 2019
Original Closing Date for Applications: May 07, 2022
Current Closing Date for Applications: May 07, 2022
Archive Date: Jun 12, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
City or township governments
Private institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Small businesses
County governments
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
Special district governments
State governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) solicits applications investigating the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the United States and globally. Because of the high incidence and frequent tumor recurrence, bladder cancer exacts an outsized medical burden. While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression, and malignancy of bladder cancer. Furthermore, our understanding of biological processes of the normal bladder at the molecular, cell and organ levels is limited. Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid our understanding of bladder cancer biology and interventions. Applications that involve multidisciplinary teams and use clinical specimens or investigate both normal and cancer processes are encouraged.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-183.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 312648 Full Announcement-PAR-19-183 -> PAR-19-183-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00248122 May 05, 2019 May 24, 2020 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00259076 May 05, 2019 Jan 24, 2022 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00269710 Oct 28, 2021 May 07, 2022 View

Package 1

Mandatory forms

312648 RR_SF424_2_0-2.0.pdf

312648 PHS398_CoverPageSupplement_4_0-4.0.pdf

312648 RR_OtherProjectInfo_1_4-1.4.pdf

312648 PerformanceSite_2_0-2.0.pdf

312648 RR_KeyPersonExpanded_2_0-2.0.pdf

312648 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

312648 RR_Budget_1_4-1.4.pdf

312648 RR_SubawardBudget30_1_4-1.4.pdf

312648 PHS398_ModularBudget_1_2-1.2.pdf

312648 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

312648 RR_SF424_2_0-2.0.pdf

312648 PHS398_CoverPageSupplement_5_0-5.0.pdf

312648 RR_OtherProjectInfo_1_4-1.4.pdf

312648 PerformanceSite_2_0-2.0.pdf

312648 RR_KeyPersonExpanded_2_0-2.0.pdf

312648 PHS398_ResearchPlan_4_0-4.0.pdf

312648 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

312648 RR_Budget_1_4-1.4.pdf

312648 RR_SubawardBudget30_1_4-1.4.pdf

312648 PHS398_ModularBudget_1_2-1.2.pdf

312648 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

312648 RR_SF424_5_0-5.0.pdf

312648 PHS398_CoverPageSupplement_5_0-5.0.pdf

312648 RR_OtherProjectInfo_1_4-1.4.pdf

312648 PerformanceSite_4_0-4.0.pdf

312648 RR_KeyPersonExpanded_4_0-4.0.pdf

312648 PHS398_ResearchPlan_4_0-4.0.pdf

312648 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

312648 RR_Budget_3_0-3.0.pdf

312648 RR_SubawardBudget30_3_0-3.0.pdf

312648 PHS398_ModularBudget_1_2-1.2.pdf

312648 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T11:29:30-05:00

Share This Post, Choose Your Platform!

About the Author: